BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 14580388)

  • 1. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.
    Marenne MN; Journet L; Mota LJ; Cornelis GR
    Microb Pathog; 2003 Dec; 35(6):243-58. PubMed ID: 14580388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y.enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus.
    Boland A; Sory MP; Iriarte M; Kerbourch C; Wattiau P; Cornelis GR
    EMBO J; 1996 Oct; 15(19):5191-201. PubMed ID: 8895564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD.
    Sarker MR; Neyt C; Stainier I; Cornelis GR
    J Bacteriol; 1998 Mar; 180(5):1207-14. PubMed ID: 9495760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG.
    Neyt C; Cornelis GR
    Mol Microbiol; 1999 Sep; 33(5):971-81. PubMed ID: 10476031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of SycD, the chaperone of the Yersinia Yop translocators YopB and YopD.
    Neyt C; Cornelis GR
    Mol Microbiol; 1999 Jan; 31(1):143-56. PubMed ID: 9987117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
    Harmon DE; Murphy JL; Davis AJ; Mecsas J
    J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors.
    Iriarte M; Sory MP; Boland A; Boyd AP; Mills SD; Lambermont I; Cornelis GR
    EMBO J; 1998 Apr; 17(7):1907-18. PubMed ID: 9524114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles.
    Mueller CA; Broz P; Müller SA; Ringler P; Erne-Brand F; Sorg I; Kuhn M; Engel A; Cornelis GR
    Science; 2005 Oct; 310(5748):674-6. PubMed ID: 16254184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Yersinia Yop virulon, a bacterial system to subvert cells of the primary host defense.
    Cornelis GR
    Folia Microbiol (Praha); 1998; 43(3):253-61. PubMed ID: 9717252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis.
    Amer AA; Gurung JM; Costa TR; Ruuth K; Zavialov AV; Forsberg Å; Francis MS
    Front Cell Infect Microbiol; 2016; 6():66. PubMed ID: 27446813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LcrV mutants that abolish Yersinia type III injectisome function.
    Ligtenberg KG; Miller NC; Mitchell A; Plano GV; Schneewind O
    J Bacteriol; 2013 Feb; 195(4):777-87. PubMed ID: 23222719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
    Viboud GI; So SS; Ryndak MB; Bliska JB
    Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for targeting of Yop effectors by the chromosomally encoded Ysa type III secretion system of Yersinia enterocolitica.
    Young BM; Young GM
    J Bacteriol; 2002 Oct; 184(20):5563-71. PubMed ID: 12270813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Yersinia Ysc-Yop virulence apparatus.
    Cornelis GR
    Int J Med Microbiol; 2002 Feb; 291(6-7):455-62. PubMed ID: 11890544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of substrates and chaperone from the Yersinia enterocolitica 1B Ysa type III secretion system.
    Foultier B; Troisfontaines P; Vertommen D; Marenne MN; Rider M; Parsot C; Cornelis GR
    Infect Immun; 2003 Jan; 71(1):242-53. PubMed ID: 12496172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
    Edqvist PJ; Aili M; Liu J; Francis MS
    Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica.
    DeBord KL; Lee VT; Schneewind O
    J Bacteriol; 2001 Aug; 183(15):4588-98. PubMed ID: 11443094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The V antigen of Yersinia pestis regulates Yop vectorial targeting as well as Yop secretion through effects on YopB and LcrG.
    Nilles ML; Fields KA; Straley SC
    J Bacteriol; 1998 Jul; 180(13):3410-20. PubMed ID: 9642196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection.
    Boland A; Cornelis GR
    Infect Immun; 1998 May; 66(5):1878-84. PubMed ID: 9573064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.